GT Biopharma GTBP
NASDAQ GTBP
$5.41 -1.90 (-25.99%)
At close: Oct 21, 2026 · 4:00 PM EDT

GT Biopharma (GTBP) Operating Expenses (2010 - 2026)

Updated

GT Biopharma's Operating Expenses was $1.99 million in Q1 2026, up 307.2% from $488,000 a year earlier but down 46.0% from the prior quarter.

Analysis

GT Biopharma (GTBP) Operating Expenses (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, GT Biopharma's Operating Expenses was $8.35 million through Mar 31, 2026, up 147.1% year-over-year; for FY2025, it was $6.85 million, up 49.9% from FY2024.

  • Operating Expenses shows a five-year compound annual growth rate of 0.2% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $4.57 million in FY2024 (-66.4%), $13.58 million in FY2023 (-36.1%), $21.26 million in FY2022 (-63.0%) and $57.52 million in FY2021 (+750.3%).
  • Quarterly Operating Expenses has moved between -$645,000 (Q4 2024) and $18.18 million (Q4 2021) over five years.
  • Compared with a year earlier, Operating Expenses was higher in two of the last six quarters, with growth averaging 14.9%.
  • The best year-over-year quarter for Operating Expenses over five years was Q4 2021 (growth of 729.7%); the worst was Q1 2022 (a decline of 81.2%).
  • Per Business Quant data, GTBP's Operating Expenses in the three quarters before Q1 2026 was $3.68 million (Q4 2025), $1.94 million (Q3 2025) and $734,000 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.95 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 10.12 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 10.56 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 12.80 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 6.09 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 9.70 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 6.54 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 18.20 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 6.68 Bn
10 GT Biopharma 6.53 Mn -16.96 Mn - 1.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.99 Mn
Dec 31, 2025 3.68 Mn
Sep 30, 2025 1.94 Mn
Jun 30, 2025 734,000.00
Mar 31, 2025 488,000.00
Dec 31, 2024 -645,000.00
Sep 30, 2024 1.92 Mn
Jun 30, 2024 1.62 Mn
Mar 31, 2024 1.66 Mn
Dec 31, 2023 3.17 Mn
Sep 30, 2023 3.12 Mn
Jun 30, 2023 3.62 Mn
Mar 31, 2023 3.67 Mn
Dec 31, 2022 5.78 Mn
Sep 30, 2022 7.02 Mn
Jun 30, 2022 3.01 Mn
Mar 31, 2022 5.44 Mn
Dec 31, 2021 18.18 Mn
Sep 30, 2021 5.95 Mn
Jun 30, 2021 4.38 Mn
API Access

GT Biopharma Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=GTBP&period=max&api_key=YOUR_API_KEY